LEVI Form 4: Director gets 85 Class A shares; 331 DERs

Levi Strauss & Co. (LEVI) disclosed a Form 4 for a director reporting equity grants on 11/04/2025.

Rhea-AI Filing Summary

Levi Strauss & Co. (LEVI) disclosed a Form 4 for a director reporting equity grants on 11/04/2025. The filing shows the acquisition of 85 shares of Class A Common Stock at $0.00, reported as dividend equivalent rights (DERs). Following this transaction, 122,701 Class A shares were beneficially owned on a direct basis.

The filing also reports 331 derivative securities acquired at $0.00, described as DERs that convey a contingent right to receive one share upon settlement; certain DERs are fully vested with a deferral delivery feature. Each share of Class B Common Stock is convertible into one Class A share at the holder’s option and has no expiration date. Derivative securities beneficially owned following the reported transactions totaled 46,500.

Insider Trade Summary

Grant/Award: 416 shares

Grant/Award 2 txns

Insider Alstead Troy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class B Common Stock	331	$0.00	$0.00
Grant/Award	Class A Common Stock	85	$0.00	$0.00

Holdings After Transaction: Class B Common Stock — 46,500 contracts (Direct); Class A Common Stock — 122,701 shares (Direct)

Footnotes (3)

1. F1. Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.
2. F2. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
3. F3. Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LEVI’s director report on Form 4?

An acquisition of 85 Class A Common Stock at $0.00 via DERs on 11/04/2025.

How many LEVI Class A shares were beneficially owned after the transaction?

122,701 Class A shares were beneficially owned on a direct basis after the transaction.

What derivative securities were reported in the LEVI Form 4?

The filing lists 331 derivative securities acquired at $0.00, described as DERs with settlement rights and deferral features.

What is a key feature of LEVI’s Class B Common Stock?

Each Class B share is convertible into one Class A share at the holder’s option and has no expiration date.

What was the total number of derivative securities beneficially owned after the transactions?

46,500 derivative securities were beneficially owned after the reported transactions.

How do the reported DERs vest for LEVI’s director?

The DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the underlying award’s grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/06/2025 - 04:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alstead Troy

(Last) (First) (Middle)

C/O LEVI STRAUSS & CO.

1155 BATTERY STREET

(Street)

SAN FRANCISCO CA 94111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LEVI STRAUSS & CO [ LEVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/04/2025		A		85(1)	A	$0.00	122,701	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	$0.00(2)	11/04/2025		A		331(3)		(2)	(2)	Class A Common Stock	331	$0.00	46,500	D

Explanation of Responses:

1. Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award.

2. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

3. Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.

	/s/ Priscilla Duncan-Tannous, Attorney-in-Fact	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.